Evidence-Based Medicine

  • Gina Perez
  • Lisa Dixon
  • Deanna L. Kelly


Ensuring the quality of medical care has not always been a priority or even a consideration for providers and purchasers of health care. However, awareness of tremendous regional variations in care provided as well as increasing awareness of poor access and suboptimal healthcare practice have brought about efforts to improve the quality of care.


Cochrane Library Postpartum Depression Treatment Team Premenstrual Dysphoric Disorder Untreated Depression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Appleby, L., Warner, R., Whitton, A., & Faragher, B. (1997). A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. British Medical Journal, 314, 932–936.PubMedGoogle Scholar
  2. Bar-Oz, B., Einarson, T., Einarson, A., Boskovic, R., O’Brien, L., Malm, H., et al. (2007). Paroxetine and congenital malformations: Meta-analysis and consideration of potential confounding factors. Clinical Therapeutics, 29(5), 918–926.CrossRefPubMedGoogle Scholar
  3. Cohen, L. S., Altshuler, L. L., Harlow, B. L., Nonacs, R., Newport, D. J., Viguera, A. C., et al. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. The Journal of the American Medical Association, 295(5), 499–507.CrossRefGoogle Scholar
  4. Dennis, C. L., Ross, L. E., & Herxheimer, A. (2008). Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD001690. doi:10.1002/14651858.CD001690.pub2.Google Scholar
  5. Dennis, C. E., & Stewart, D. (2004). Treatment of postpartum depression, part 1: A critical review of biological interventions. The Journal of Clinical Psychiatry, 65, 1242–1251.CrossRefPubMedGoogle Scholar
  6. Entsuah, A. R., Huang, H., & Thase, M. (2001). Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors or placebo. The Journal of Clinical Psychiatry, 62, 869–877.CrossRefPubMedGoogle Scholar
  7. Frederikse, M., Petrides, G., & Kellner, C. (2006). Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: A response to the National Institute for Clinical Excellence Report. The Journal of ECT, 22, 13–17.CrossRefPubMedGoogle Scholar
  8. Furukawa, T. A., Streiner, D. L., Young, L. T., & Kinoshita, Y. (2001). Antidepressants plus benzodiazepines for major depression. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD001026. doi: 10.1002/14651858.CD001026.Google Scholar
  9. Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., et al. (2004). Modulation of cortical-limbic pathways in major depression. Treatment specific effects of cognitive behavioral therapy. Archives of General Psychiatry, 61, 34–41.CrossRefPubMedGoogle Scholar
  10. Guaiana, G., Barbui, C., & Hotopf, M. (2007). Amitriptyline for depression. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD004186. doi: 10.1002/14651858.CD004186.pub2. Google Scholar
  11. Hallberg, P., & Sjöblom, V. (2005). The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: A review and clinical aspects. Journal of Clinical Psychopharmacology, 25(1), 59–73.CrossRefPubMedGoogle Scholar
  12. Hatala, R., Keitz, S., Wyer, P., & Guyatt, G. (2005). Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. Canadian Medical Association Journal, 172(5), 661–665.CrossRefGoogle Scholar
  13. Heikkinen, T., Ekblad, U., & Laine, K. (2001). Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta. Psychopharmacology, 153, 450–454.CrossRefPubMedGoogle Scholar
  14. Hendrick, V., Altshuler, L., Strouse, T., & Grosser, S. (2000). Postpartum and nonpostpartum depression: Differences in presentation and response to pharmacologic treatment. Depression and Anxiety, 11, 66–72.CrossRefPubMedGoogle Scholar
  15. Hendrick, V., Stowe, Z. N., Altshuler, L. L., Hwang, S., Lee, E., & Haynes, D. (2003). Placental passage of antidepressant medications. The American Journal of Psychiatry, 160, 993–996.CrossRefPubMedGoogle Scholar
  16. Hoffbrand, S. E., Howard, L., & Crawley, H. (2001). Antidepressant treatment for post-natal depression. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002018. doi: 10.1002/14651858.CD002018.Google Scholar
  17. Howard, L. M., Hoffbrand, S., Henshaw, C., Boath, L., & Bradley, E. (2005). Antidepressant prevention of postnatal depression. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD004363. doi: 10.1002/14651858.CD004363.pub2.Google Scholar
  18. Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., et al. (2000). Gender differences in treatment response to sertraline versus imipramine in chronic depression. The American Journal of Psychiatry, 157, 1445–1452.CrossRefPubMedGoogle Scholar
  19. Linde, K., Berner, M. M., & Kriston, L. (2008). St John’s wort for major depression. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000448. doi:10.1002/14651858.CD000448.pub3.Google Scholar
  20. McDonald, W. (2006). Is ECT cost-effective? A review of the National Institute of Health and Clinical Excellence’s report on the economic analysis of ECT. The Journal of ECT, 22, 25–29.CrossRefPubMedGoogle Scholar
  21. Mead, G. E., Morley, W., Campbell, P., Greig, C. A., McMurdo, M., & Lawlor, D. A. (2008). Exercise for depression. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004366. doi: 10.1002/14651858.CD004366.pub3.Google Scholar
  22. Moncrieff, J., Wessely, S., & Hardy, R. (2004). Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD003012. doi: 10.1002/14651858.CD003012.pub2.Google Scholar
  23. Oren, D. A., Wisner, K. L., Spinelli, M., Epperson, C. N., Peindl, K. S., Terman, J. S. et al. (2002). An open trial of morning light therapy for treatment of antepartum depression. The American Journal of Psychiatry, 159, 666–669.CrossRefPubMedGoogle Scholar
  24. Sackett, D., Rosenberg, W., Gray, J., Haynes, R., & Richardson, W. (1996). Evidence based medicine: What it is and what it isn’t. British Medical Journal, 312, 71–72.PubMedGoogle Scholar
  25. Shah, N. R., Jones, J. B., Aperi, J., Shentov, R., Karne, A., & Borenstein, J. (2008). Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. A meta-analysis. Obstetrics and Gynecology, 111, 1175–1182.CrossRefPubMedGoogle Scholar
  26. Smith, C. A., & Hay, P. P. J. (2004). Acupuncture for depression. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD004046. doi: 10.1002/14651858.CD004046.pub2.Google Scholar
  27. Stowe, Z. N., Casarella, J., Landry, J., & Nemeroff, C. B. (1995). Sertraline in the treatment of women with postpartum major depression. Depression, 3, 49–55.CrossRefGoogle Scholar
  28. Suppaseemanont, W. (2006). Depression in drug safety and nursing management. American Journal of Maternal Child Nursing, 31(1), 10–15.CrossRefPubMedGoogle Scholar
  29. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A., Warden, D., & Ritz, L. (2006). Evaluation of outcomes for depression using measurement-based care in Star*D: Implications for clinical practice. The American Journal of Psychiatry, 163, 28–40.CrossRefPubMedGoogle Scholar
  30. Use of Paxil CR or Paxil during pregnancy. (2005). Retrieved December 10, 2008, from
  31. Wisner, K. L., Zarin, D. A., Holmboe, E. S., Appelbaum, P. S., Gelenberg, A. J., Leonard, H. L., et al. (2000). Risk-benefit decision making for treatment of depression during pregnancy. The American Journal of Psychiatry, 157, 1933–1940.CrossRefPubMedGoogle Scholar
  32. Yonkers, K. A., Halbreich, U., Freeman, E., Brown, C., Endicott, J., & Frank, E. (1997). Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial. The Journal of the American Medical Association, 278, 983–988.CrossRefGoogle Scholar
  33. Zwarenstein, M., & Reeves, S. (2006). Knowledge translation and interprofessional collaboration: Where the rubber of evidence-based care hits the road of teamwork. The Journal of Continuing Education in the Health Professions, 26, 46–54.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Gina Perez
    • 1
  • Lisa Dixon
  • Deanna L. Kelly
  1. 1.School of MedicineUniversity of MarylandBaltimoreUSA

Personalised recommendations